维普中文期刊产品整合服务
72篇 您的检索式:作者名="Sandri L"
    题名 作者 年代 出处 被引量
1Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients显示文摘AIM: To simultaneously evaluate the presence of defects in gallbladder and gastric emptying, as well as in intestinal transit in gallstone patients (GS) and the effect of chronic ursodeoxycholic acid (UDCA) administration on these parameters and on serum bile acids and clinical outcome in GS and controls (CTR). METHODS: After a standard liquid test meal, gallbla-dder and gastric emptying (by ultrasound), oroileal transit time (OITT) (by an immunoenzymatic technique) and serum bile acids (by HPLC) were evaluated before and after 3 mo of UDCA (12 mg/kg bw/d) or placebo administration in 10 symptomatic GS and 10 matched healthy CTR. RESULTS: OITT was longer in GS than in CTR (P < 0.0001); UDCA significantly reduced OITT in GS (P < 0.0001), but not in CTR. GS had longer gastric half-emptying time (t1/2) than CTR (P < 0.0044) at baseline; after UDCA, t1/2 significantly decreased (P < 0.006) in GS but not in CTR. Placebo administration had no effect on gastric emptying and intestinal transit in both GS and CTR. CONCLUSION: The gallstone patient has simultaneous multiple impairments of gallbladder and gastric emptying, as well as of intestinal transit. UDCA administration restores these defects in GS, without any effect in CTR. These results confirm the pathogenetic role of gastrointestinal motility in gallstone disease and suggest an additional mechanism of action for UDCA in reducing bile cholesterol supersaturation.A Colecchia G Mazzella L Sandri F Azzaroli M Magliuolo P Simoni ML Bacchi-Reggiani E Roda D Festi 2006World Journal of Gastroenterology2006,12,33:4
2Signalling pathways regula- ring muscle mass in ageing skeletal muscle : the role of the IGF1-Akt- mTOR-FoxO pathway 显示文摘Sandri M Barberi L Bijlsma A Y 2013Biogerontolagy2013,14,3:1
3Amphipathic, alpha-helical antimierobial peptides显示文摘Tossi A Sandri L Giangaspero A 2000Biopolymers2000,55,1:1
4Hermite expansions of compact support waveforms: Applications to myoelectrie signals显示文摘LO CONTE L R MERLETTI R SANDRI G V 1994IEEE Transactions on Biomedical Engineering1994,41,12:1
5Minor increases in plasma troponin I predict decreased left ventricular ejection fraction after high-dose chemotherapy显示文摘Sandri MT Cardinale D Zorzino L 2003Clin Chem2003,49,2:1
6Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery显示文摘Sandri MT Zorzino L Cassatella MC 2010Ann Surg Oncol2010,17,6:1
7Molecular Diversity in Gene-encoded,Cationic Antimicrobial Polypeptides显示文摘 Sandri L 2002Current Pharmaceutical Design2002,8,:1
8Signalling pathways reg- ulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway 显示文摘Sandri M Barberi L Bijlsma A Y 2013Biogerontology2013,14,3:1
9Amphipathic a helical antimicrobial peptides显示文摘Giangaspero A Sandri L Tossi A 0,,21:1
10Safety of interferon beta treatment for chronic HCV hepatitis 显示文摘Festi D Sandri L Mazzella G 2004World J Gastroenterol2004,10,:1
11Gallbladder cholesterol polyps and cholesterolosis 显示文摘Sandri L Colecchia A Lamcca A 2003Minerva Gastroenterol Dietol2003,49,:1
12Amphipathic alpha helical antimicrobial peptices显示文摘GIANGASPERO A SANDRI L TOSSI A 2001Eur J Biochem2001,268,21:1
13Posttranslational modifications control FoxO3 activity during denervation 显示文摘Bertaggia E Coletto L Sandri M 2012Am J Physiol Cell Physiol2012,302,3:1
14A Bayesian procedure for probabilistic tsunami hazard assessment 显示文摘Grezio A Marzocchi W Sandri L 2010Natural hazards2010,53,01:1
15Frequency response requirements for fluctuating wind pressure measurements显示文摘LETCHFORD C W SANDRI P LEVITAN M L 1992J Wind Eng Ind Aerodyn1992,40,3:1
16Amphipathic, alpha-helical antimicrobial peptides显示文摘l'ossi A Sandri L Giangaspero A 2000Biopolymers2000,55,1:1
17The 2B myosin heavy chain gene is expressed in human skeletal muscle显示文摘Andersen J L Weissn A Sandri C 2002Journal of Physiology2002,,93:1
18Apoptosis in the skeletal muscle of patients with heart failure:investigation of clinical and biochemical changes显示文摘Vescovo G Volterrani M Zennaro R Sandri M Ceconi C Lorusso R Ferrari R Ambrosio GB and Dalla Libera L Heart0,2000,:1
19Safety of interferon beta treatment for chronic HCV hepatitis显示文摘Festi D Sandri L Mazzella G 2004World J Gastroenterol2004,10,1:1
20Amphipathic alpha helical an timicrobial peptides显示文摘Giangaspero A Sandri L Tossi A 2001Eur J Biochem2001,268,21:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费